蛋白質表徵市場－全球產業規模、佔有率、趨勢、機會和預測（按產品與服務、應用、最終用途、地區和競爭細分，2020-2030 年）

2024 年全球蛋白質表徵市場價值為 154.5 億美元，預計到 2030 年將達到 340.7 億美元，複合年成長率為 14.06%。隨著人們越來越重視蛋白質體學及其在理解細胞功能和疾病機制中的作用，全球蛋白質表徵市場正在強勁擴張。蛋白質作為關鍵的生物標記和治療標靶，是藥物發現、診斷和個人化醫療的核心。這促使生物技術和製藥公司投資先進的蛋白質分析技術。質譜、色譜和電泳等工具被廣泛用於研究蛋白質結構、翻譯後修飾和相互作用。對精準醫療和生物製劑的需求不斷成長，進一步加速了對精確蛋白質分析的需求。政府對生命科學研究的資助不斷增加，學術機構和產業參與者之間的合作不斷增多，這些都支持著市場的擴張。

塑造市場的趨勢包括將人工智慧和機器學習融入蛋白質分析，從而加快資料處理和預測建模速度。自動化和高通量篩選技術正在縮短分析時間並提高可重複性，使蛋白質表徵在大規模應用中更有效率。多組學方法的出現，將蛋白質組學與基因組學和代謝組學相結合，正在加深對生物學的洞察，並促進全面分析。微型化和晶片實驗室平台在即時診斷應用（尤其是在臨床診斷領域）中越來越受歡迎。業內人士也致力於開發方便用戶使用的軟體工具，以實現無縫的資料整合、解讀和視覺化，幫助研究人員加速發現。

關鍵市場促進因素

生物製劑和生物相似藥需求不斷成長

主要市場挑戰

儀器和分析服務成本高昂

主要市場趨勢

單株抗體和生物製劑開發的興起

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球蛋白質表徵市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依產品及服務（消耗品、儀器、服務）
  • 按應用（藥物研發、臨床診斷、其他）
  • 依最終用途（製藥和生物技術公司、學術研究機構、合約研究組織、其他）
  • 按公司分類（2024）
  • 按地區
• 市場地圖

第6章：北美蛋白質表徵市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 墨西哥
  • 加拿大

第7章：歐洲蛋白質表徵市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太蛋白質表徵市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 韓國
  • 日本
  • 澳洲

第9章：南美洲蛋白質表徵市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東與非洲蛋白質表徵市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 合併與收購（如有）
• 產品發布（如有）
• 最新動態

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 14 章：競爭格局

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Eurofins Scientific
• Merck KGAA
• Promega Corporation
• Qiagen NV
• Sartorius AG

第 15 章：策略建議

第16章調查會社について,免責事項

Global Protein Characterization Market was valued at USD 15.45 Billion in 2024 and is expected to reach USD 34.07 Billion by 2030 with a CAGR of 14.06%. The Global Protein Characterization Market is witnessing robust expansion due to the growing emphasis on proteomics and its role in understanding cellular functions and disease mechanisms. Proteins, being key biomarkers and therapeutic targets, are central to drug discovery, diagnostics, and personalized medicine. This has prompted biotechnology and pharmaceutical companies to invest in advanced protein analysis technologies. Tools such as mass spectrometry, chromatography, and electrophoresis are widely used to study protein structure, post-translational modifications, and interactions. Increasing demand for precision medicine and biologics has further accelerated the need for accurate protein profiling. Rising government funding for life sciences research and an uptick in collaborations between academic institutions and industry players are supporting the market's expansion.

Trends shaping the market include the integration of artificial intelligence and machine learning in protein analysis, enabling faster data processing and predictive modeling. Automation and high-throughput screening technologies are reducing analysis time and improving reproducibility, making protein characterization more efficient for large-scale applications. The emergence of multi-omics approaches, combining proteomics with genomics and metabolomics, is enhancing the depth of biological insights and encouraging comprehensive profiling. Miniaturized and lab-on-chip platforms are gaining traction for point-of-care applications, especially in clinical diagnostics. Industry players are also focusing on developing user-friendly software tools that allow seamless data integration, interpretation, and visualization, helping researchers accelerate discoveries.

Key Market Drivers

Rising Demand for Biologics and Biosimilars

The increasing demand for biologics and biosimilars is a significant driver for the Global Protein Characterization Market. Biologics, including monoclonal antibodies, therapeutic proteins, and vaccines, are revolutionizing the treatment of various diseases, particularly in oncology, autoimmune disorders, and genetic diseases. As these therapies continue to grow in importance, the need for precise and comprehensive protein characterization and identification becomes crucial. Protein characterization techniques allow for the analysis of protein structures, functions, and interactions, which is vital for ensuring the safety, efficacy, and quality of biologic drugs.

In 2023, the U.S. Food and Drug Administration (FDA) approved 55 new drugs, of which 17 were biologics, accounting for 30.9% of all drug approvals. Notably, 12 of these biologics were monoclonal antibodies, marking a significant milestone in biologic drug development. The Center for Biologics Evaluation and Research (CBER) added 23 new biologics license application approvals in 2023, highlighting the growing focus on biologic therapies.

Similarly, the European Medicines Agency (EMA) recommended 77 medicines for marketing authorization in 2023, with 39 having a new active substance. This indicates a strong emphasis on innovative therapies, including biologics, in the European market.

The increasing focus on biosimilars, which are similar to original biologic drugs but at a lower cost, further fuels the demand for protein characterization. As the patents of several blockbuster biologics expire, pharmaceutical companies are investing heavily in the development of biosimilars to tap into this growing market. Ensuring the structural and functional similarity of biosimilars to their reference biologics is critical, and this requires advanced protein characterization methods such as mass spectrometry, chromatography, and peptide mapping.

Regulatory agencies worldwide, including the FDA and EMA, have established rigorous guidelines to assess the quality and safety of biologics and biosimilars, which in turn drives the need for precise protein identification techniques. As biologic therapies gain popularity and the biosimilars market expands, the demand for protein characterization and identification solutions will continue to rise, accelerating market growth and innovation in this sector.

Key Market Challenges

High Cost of Instruments and Analytical Services

The high cost of instruments and analytical services remains a significant challenge for the Global Protein Characterization Market. Cutting-edge protein characterization tools such as mass spectrometers, chromatography systems, and protein analyzers are critical for accurate and reliable results. These advanced instruments often come with hefty price tags, making them unaffordable for smaller research institutions, universities, and laboratories, particularly in emerging markets. The expense associated with these technologies can create a barrier to entry for organizations with limited financial resources, thereby hindering widespread adoption of advanced protein characterization methods.

Beyond the high initial purchase cost, maintaining and operating these instruments requires specialized training, skilled personnel, and regular servicing, all of which add to the ongoing expenses. The need for highly trained technicians and scientists to operate these advanced technologies further drives up operational costs. Additionally, the reliance on specialized reagents and consumables for protein analysis can contribute to the overall expense. For many research entities, these financial constraints may limit the frequency of protein characterization studies and the scope of their research projects.

Key Market Trends

Rise in Monoclonal Antibody and Biologics Development

The rise in monoclonal antibody (mAb) and biologics development is significantly driving the Global Protein Characterization Market. With the growing emphasis on biologic therapies, including monoclonal antibodies, protein characterization and identification have become essential to ensuring the safety, efficacy, and consistency of these therapies. As biologics are increasingly utilized for treating chronic diseases, cancers, and autoimmune conditions, accurate protein analysis is vital to understanding their molecular structures, functionality, and therapeutic potential. This trend is particularly pronounced with the growing use of mAbs, which are highly complex molecules that require precise characterization for both drug development and regulatory approval.

The growing complexity of biologics has led to increased demand for advanced proteomics tools, such as mass spectrometry and chromatography, to analyze proteins and their interactions. This demand is expected to rise as the pharmaceutical industry focuses on personalized medicine, where the detailed profiling of proteins in the context of individual patients is crucial. Accurate protein identification is pivotal in the development of next-generation biologics, as even slight structural variations can impact the therapeutic outcome.

Key Market Players

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Eurofins Scientific
• Merck KGAA
• Promega Corporation
• Qiagen N.V.
• Sartorius AG

Report Scope:

In this report, the Global Protein Characterization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Characterization Market, By Product & Services:

• Consumables
• Instruments
• Services

Protein Characterization Market, By Application:

• Drug Discovery & Development
• Clinical Diagnosis
• Others

Protein Characterization Market, By End-Use:

• Pharmaceuticals & Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations
• Others

Protein Characterization Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Protein Characterization Market.

Available Customizations:

Global Protein Characterization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Protein Characterization Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product & Services (Consumables, Instruments, Services)
  • 5.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
  • 5.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Protein Characterization Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product & Services
  • 6.2.2. By Application
  • 6.2.3. By End-Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Protein Characterization Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product & Services
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-Use
  • 6.3.2. Mexico Protein Characterization Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product & Services
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-Use
  • 6.3.3. Canada Protein Characterization Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product & Services
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-Use

7. Europe Protein Characterization Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product & Services
  • 7.2.2. By Application
  • 7.2.3. By End-Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Protein Characterization Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product & Services
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-Use
  • 7.3.2. Germany Protein Characterization Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product & Services
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-Use
  • 7.3.3. United Kingdom Protein Characterization Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product & Services
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-Use
  • 7.3.4. Italy Protein Characterization Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product & Services
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-Use
  • 7.3.5. Spain Protein Characterization Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product & Services
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-Use

8. Asia-Pacific Protein Characterization Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product & Services
  • 8.2.2. By Application
  • 8.2.3. By End-Use
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Protein Characterization Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product & Services
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-Use
  • 8.3.2. India Protein Characterization Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product & Services
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-Use
  • 8.3.3. South Korea Protein Characterization Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product & Services
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-Use
  • 8.3.4. Japan Protein Characterization Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product & Services
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-Use
  • 8.3.5. Australia Protein Characterization Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product & Services
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-Use

9. South America Protein Characterization Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product & Services
  • 9.2.2. By Application
  • 9.2.3. By End-Use
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Protein Characterization Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product & Services
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-Use
  • 9.3.2. Argentina Protein Characterization Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product & Services
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-Use
  • 9.3.3. Colombia Protein Characterization Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product & Services
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-Use

10. Middle East and Africa Protein Characterization Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product & Services
  • 10.2.2. By Application
  • 10.2.3. By End-Use
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Protein Characterization Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product & Services
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-Use
  • 10.3.2. Saudi Arabia Protein Characterization Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product & Services
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-Use
  • 10.3.3. UAE Protein Characterization Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product & Services
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Agilent Technologies, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Bio-Rad Laboratories, Inc.
• 14.3. Bruker Corporation
• 14.4. Thermo Fisher Scientific Inc.
• 14.5. Danaher Corporation
• 14.6. Eurofins Scientific
• 14.7. Merck KGAA
• 14.8. Promega Corporation
• 14.9. Qiagen N.V.
• 14.10. Sartorius AG

15. Strategic Recommendations

16. About Us & Disclaimer